SK Biopharaceuticals set to make splash after IPO
By Chung Joo-won
SEOUL, July 1 (Yonhap) -- SK Biopharamceuticals Co. Ltd., a unit of South Korean conglomerate SK Group, will make a debut on the local bourse this week, probably emerging as the top pick by investors for its growth potential amid the coronavirus pandemic.
The initial public offering (IPO) price of SK Biopharmaceutical was set at 49,000 won (US$40.73), and the company will raise some 1 trillion won from the market debut, the largest IPO of the year so far, according to the Korea Exchange, the country's bourse operator.
The drugmaker's market cap is estimated at roughly 3.84 trillion won, but analysts put the market value of SK Biopharmaceuticals at up to 6 trillion won.
In 2019, SK Pharmaceutical's sales stood at 123.8 billion won but suffered a net loss of 91 billion won.
SK Group is the listed company's largest shareholder with a 75 percent stake. In 2011, SK Biopharmaceuticals was spun off from SK Group's life science unit.
Prior to its IPO, investors had rushed to buy SK Pharmaceuticals, chipping in 31 trillion won in deposits to buy its stocks, the largest in the country's IPO history. The previous record was 30.1 trillion won in 2014 for Cheil Industries Co., a holding company of the country's leading conglomerate Samsung Group.
In November, SK Biopharmaceuticals was the first South Korean company to independently develop an investigational anti-epileptic drug, Cenobamate, with approval from the U.S. Food and Drug Administration (FDA).
jwc@yna.co.kr
(END)
-
Opposition leader calls on Yoon to reject imports of products from Japan's Fukushima
-
S. Korea to allow online permit-free entry for tourists from 22 nations to spur spending
-
DP leader says Yoon should have stormed out of summit with Japan if Dokdo issue raised
-
One-third of senior public officials have over 2 bln won in personal wealth: data
-
(LEAD) U.S. Forces Korea holds first deployment training of THAAD 'remote' launcher
-
S. Korea to allow online permit-free entry for tourists from 22 nations to spur spending
-
(LEAD) U.S. Forces Korea holds first deployment training of THAAD 'remote' launcher
-
Grandson of ex-President Chun apprehended at Incheon Int'l Airport over drug use
-
One-third of senior public officials have over 2 bln won in personal wealth: data
-
(3rd LD) S. Korea to seek extradition of crypto fugitive Kwon from Montenegro
-
(LEAD) (News Focus) Abrupt replacement of national security adviser gives rise to much speculation
-
(2nd LD) N. Korea plans to send weapons, munitions to Russia in exchange for food: NSC
-
Grandson of ex-President Chun released after investigation over drug use
-
S. Korea releases report on N. Korea's human rights violations
-
National Assembly consents to arrest of PPP lawmaker Ha